Erratum to microRNA-155 inhibition attenuates myocardial infarction-induced connexin 43 degradation in cardiomyocytes by reducing pro-inflammatory macrophage activation
Erratum to: Cardiovasc Diagn Ther 2022;12:325-39
This article (1) titled “MicroRNA-155 inhibition attenuates myocardial infarction-induced connexin 43 degradation in cardiomyocytes by reducing pro-inflammatory macrophage activation” (doi: 10.21037/cdt-21-743), unfortunately contains an error in Figure 2. The picture of Figure 2A was uploaded mistakenly. The corrected Figure 2 can be found below.
Corrected Figure 2:
The authors apologize for the mistake.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Yang HT, Li LL, Li SN, et al. MicroRNA-155 inhibition attenuates myocardial infarction-induced connexin 43 degradation in cardiomyocytes by reducing pro-inflammatory macrophage activation. Cardiovasc Diagn Ther 2022;12:325-39. [Crossref] [PubMed]
